Century Therapeutics, Inc.IPSCNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank50
3Y CAGR-76.0%
Studio
Year-over-Year Change

Price-to-sales ratio

3Y CAGR
-76.0%/yr
Annual compound
Percentile
P50
Within normal range
vs 3Y Ago
0x
Contraction
Streak
2 yr
Consecutive declineCompressed
PeriodValueYoY Change
20250.79-93.5%
202412.06-86.3%
202388.11+54.6%
202256.99-
20210.00-
20200.00-
20190.00-